BHIC.US BHIC

Healthcare Pharmaceutical Retailers USA Stocks
5.03 USD
Close of Nov 11, 2026
1.59 9.89
Market cap
USD 59.1M
P/E
-
P/B
32.22x
ROE
-45.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is BHIC.US undervalued?

Graham number

The Graham number of BHIC cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BHIC fundamental analysis

No fundamental analysis for BHIC yet.

BHIC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BHIC

BioScience Health Innovations, Inc. operates as a health and wellness innovation company focuses on mitochondrial health science, advanced peptide delivery, and metabolic care in the United States. It offers nutritional supplements, peptides, and bioactive compounds through its core technology Mineral Oxide Delivery System, as well as provides Oracle NetSuite, an accounting and financial reporting system. The company also provides services, including testosterone and hormona…

Full company profile